WATSON 3450 30 mg Pill: purple white, capsule/oblong, 16mm
The pill with imprint WATSON 3450 30 mg (Purple / White, Capsule/Oblong, 16mm) has been identified as Morphine Sulfate Extended Release 30 mg and is used for Chronic Pain, Neonatal Abstinence Syndrome, and Pain. It belongs to the drug class Opioids (narcotic analgesics) and is classified as CSA Schedule 2 (High potential for abuse).
Images for WATSON 3450 30 mg
Morphine Sulfate Extended Release
- Imprint
- WATSON 3450 30 mg
- Strength
- 30 mg
- Color
- Purple / White
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3450 (Discontinued)
- Inactive Ingredients
-
corn starch,
diethyl phthalate,
ethylcellulose,
polyethylene glycol 6000,
sucrose,
povidone k30,
magnesium silicate,
ferrosoferric oxide,
gelatin,
propylene glycol,
titanium dioxide,
FD&C Blue No. 1,
FD&C Red No. 3,
hypromellose 2910 (5 mPa.s),
methacrylic acid - ethyl acrylate copolymer (1:1) type a
Note: Inactive ingredients may vary.
See also:
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (367)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
Other brands
MS Contin, Roxanol, Duramorph, Kadian, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Duramorph, Kadian, Astramorph PF, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.